JP Morgan Chase’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Sell
511,400
-510,000
-50% -$7.18M ﹤0.01% 3231
2025
Q4
$14.7M Sell
1,021,400
-937,300
-48% -$16.2M ﹤0.01% 2336
2025
Q3
$37.1M Buy
1,958,700
+1,110,000
+131% +$18.3M ﹤0.01% 1614
2025
Q2
$18.2M Buy
848,700
+745,600
+723% +$11.1M ﹤0.01% 2025
2025
Q1
$1.35M Buy
+103,100
New +$1.53M ﹤0.01% 4146

Other funds holding OSCR

JP Morgan Chase's OSCR Position: Q1 2026 in Review

JP Morgan Chase increased its Oscar Health (OSCR) stake by 57% in Q1 2026, buying an estimated $6.12M and bringing the position to 1,196,634 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

JP Morgan Chase first reported a position in OSCR in Q2 2021 and has held it in 20 quarters since. The position peaked at $213M in Q2 2025. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • JP Morgan Chase held 1,196,634 shares of Oscar Health worth $13M as of Q1 2026.
  • JP Morgan Chase bought 434,685 Oscar Health shares in Q1 2026, an estimated $6.12M.
  • Oscar Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2449 holding.
  • JP Morgan Chase first reported a position in Oscar Health in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Oscar Health position peaked at $213M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.